cyclen has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkaraju, G; Annunziata, O; da Costa, VC; Gonzalez, P; Green, KN; Hyde, K; Rizo, J; Wu, Q | 1 |
| Chen, YX; Chu, TT; Hu, ZW; Li, QQ; Li, YM; Qiu, T; Sun, ZY; Zhao, YF | 1 |
2 other study(ies) available for cyclen and Alzheimer Disease
| Article | Year |
|---|---|
Bimodal-hybrid heterocyclic amine targeting oxidative pathways and copper mis-regulation in Alzheimer's disease.
Topics: Alzheimer Disease; Amines; Amyloid; Animals; Cell Line; Copper; Cyclams; Heterocyclic Compounds; Humans; Mice; Models, Biological; Nuclear Magnetic Resonance, Biomolecular; Oxidation-Reduction; Thioctic Acid | 2014 |
Clearance of the intracellular high level of the tau protein directed by an artificial synthetic hydrolase.
Topics: Alzheimer Disease; Copper; Cyclams; Drug Design; Heterocyclic Compounds; Hydrolases; Molecular Structure; Protein Aggregation, Pathological; Recombinant Proteins; tau Proteins | 2014 |